These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5502468)

  • 21. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tadip in the treatment of arterial hypertension].
    Markiewicz M
    Pol Tyg Lek; 1970 Dec; 25(52):2036-8. PubMed ID: 5495546
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prolonged treatment of arterial hypertension with sympathetic inhibitors].
    Capris TA; Fernández Moores AJ; Cosentino JJ
    Medicina (B Aires); 1967; 27(1):27-36. PubMed ID: 5594902
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of elemental arterial hypertension by a new imidazole derivative].
    Valdés EF; Mendoza R; Gonçalves N
    Prensa Med Argent; 1967 Nov; 54(37):2068-71. PubMed ID: 5613692
    [No Abstract]   [Full Text] [Related]  

  • 25. [Behavior of the electrocardiogram and radionephrogram during long-term treatment of arterial hypertension with 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Curri G
    Clin Ter; 1970 Jun; 53(6):527-46. PubMed ID: 5527428
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical experience with Catapresan].
    Laux L; Angelmann W
    Med Monatsschr; 1967 Apr; 21(4):186-7. PubMed ID: 5584446
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experience with Catapresan in the therapy of hypertension].
    Michel D
    Dtsch Med Wochenschr; 1968 Jul; 93(28):1375. PubMed ID: 5657231
    [No Abstract]   [Full Text] [Related]  

  • 28. [Beta-adrenergic blockers and renin-angiotensin-aldosterone system in healthy individuals and patients with arterial hypertension].
    Miranda B; Ruilope L; Mancheño E; Arribas F; García-Robles R; Alcázar JM; Nieto J; Sancho J; Rodicio JL
    Med Clin (Barc); 1984 Nov; 83(14):572-4. PubMed ID: 6513646
    [No Abstract]   [Full Text] [Related]  

  • 29. [A drug for the treatment of essential hypertension].
    Meoni S; Costa S; Rossi R
    Minerva Med; 1971 Apr; 62(30):1581-7. PubMed ID: 5556771
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dopegyt (alpha-methyldopa) in arterial hypertension].
    Kedra M; Koziara Z
    Pol Tyg Lek; 1971 Jun; 26(25):963-5. PubMed ID: 5564519
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of an imidazoline derivative on arterial hypertension with or without associated toxemia].
    Delgado Urdapilleta J; Castro Carvajal F
    Ginecol Obstet Mex; 1969 Mar; 25(149):253-6. PubMed ID: 5780802
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical use of atenolol (Tenormin) in arterial hypertension].
    Beloev I; Popiliev I; Tŭrnovska R; Pelov R
    Vutr Boles; 1982; 21(4):36-41. PubMed ID: 6755910
    [No Abstract]   [Full Text] [Related]  

  • 33. [A drug for therapy of essential hypertension].
    Meoni S; Costa S; Rossi R
    Minerva Med; 1971 Apr; 62(30):1581-7. PubMed ID: 5577288
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trial with 2-guanidinomethyl (1,4) benzodioxan in hypertension.
    Malhotra RP; Khurana SB; Singh S
    J Indian Med Assoc; 1967 Jan; 48(2):69-74. PubMed ID: 6038525
    [No Abstract]   [Full Text] [Related]  

  • 35. [Captopril (Capoten) as a therapeutic adjuvant in the treatment of therapy-resistant hypertension].
    Ekelund B; Ladefoged J
    Ugeskr Laeger; 1983 May; 145(22):1682-5. PubMed ID: 6349073
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the evaluation of therapeutic effects in hypertension (described by the example of Guanoxan)].
    Siedek H; Klein K; Grübl M
    Munch Med Wochenschr; 1965 Oct; 107(43):2119-24. PubMed ID: 5899029
    [No Abstract]   [Full Text] [Related]  

  • 37. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
    Koch G
    Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of arterial hypertension with the Soviet-made beta-blockader anaprilin].
    Shul'ga IuD; Zharko KP
    Ter Arkh; 1974; 46(9):57-61. PubMed ID: 4439308
    [No Abstract]   [Full Text] [Related]  

  • 39. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of ganglionic block on hematic and urinary dynamics of catecholamines in arterial hypertension].
    Consolo F; Scaffidi L; Arrigo F
    Cuore Circ; 1970 Jun; 54(3):99-113. PubMed ID: 4394251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.